TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results

TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-09, Vol.72 (13), p.B174-B174
Hauptverfasser: Bouras, Georgios, Abizaid, Alexandre, Lutz, Matthias, Carrie, Didier, Weber-Albers, Joachim, Dudek, Darius, Gambone, Louise, Anderson, Jeffrey, Lansky, Alexandra
Format: Artikel
Sprache:eng
Schlagworte:
Biocompatibility
Biomedical materials
Cardiology
Rapamycin
Success
Surgical implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page B174
container_issue 13
container_start_page B174
container_title Journal of the American College of Cardiology
container_volume 72
creator Bouras, Georgios
Abizaid, Alexandre
Lutz, Matthias
Carrie, Didier
Weber-Albers, Joachim
Dudek, Darius
Gambone, Louise
Anderson, Jeffrey
Lansky, Alexandra
description
doi_str_mv 10.1016/j.jacc.2018.08.1597
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2113204061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109718376046</els_id><sourcerecordid>2113204061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2217-25c9d00f20b5376a1a7f8995fcd44b416d2a1604ad9180e9f133c76ed26134df3</originalsourceid><addsrcrecordid>eNp9kUuOEzEQhi0EEiFwAjYlIbHrHj_6icRiaE0zkWYIImFtOX4wbrnbwXYzyo47cAuOxUnoKKxZVZX0_6X660PoNcE5waS6GvJBSJlTTJocNzkp2_oJWpGybDK29E_RCteszAhu6-foRYwDxrhqSLtCv_fdPisYhf760357D5sNpGCFewc7YXQ6wVv4rIPxYRST1LBLszqBN5AeNPRiSn6EnQ3e2XGO2Y2bk52-wQfrg44-HMTBaeh88JMIJ9hJYYx3Cv78_AW0yO79lB6g9875x2w-QufsZKVwsJ2T9KOO0NtpGb_oOLsUX6JnRrioX_2ra_S1v9l3t9nd9uOmu77LJKWkzmgpW4WxofhQsroSRNSmadvSSFUUh4JUigpS4UKoljRYt4YwJutKK1oRVijD1ujNZe8x-O-zjokPfg7LIZFTQhjFBV6Ua8QuKhl8jEEbfgx2XGJygvkZCh_4GQo_Q-G44Wcoi-v9xaWXAD-sDjxKq5fPKhu0TFx5-1__X0WTlb8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2113204061</pqid></control><display><type>article</type><title>TCT-432 FANTOM II trial: Safety &amp; Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bouras, Georgios ; Abizaid, Alexandre ; Lutz, Matthias ; Carrie, Didier ; Weber-Albers, Joachim ; Dudek, Darius ; Gambone, Louise ; Anderson, Jeffrey ; Lansky, Alexandra</creator><creatorcontrib>Bouras, Georgios ; Abizaid, Alexandre ; Lutz, Matthias ; Carrie, Didier ; Weber-Albers, Joachim ; Dudek, Darius ; Gambone, Louise ; Anderson, Jeffrey ; Lansky, Alexandra</creatorcontrib><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2018.08.1597</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Biocompatibility ; Biomedical materials ; Cardiology ; Rapamycin ; Success ; Surgical implants</subject><ispartof>Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B174-B174</ispartof><rights>2018</rights><rights>Copyright Elsevier Limited Sep 25, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2217-25c9d00f20b5376a1a7f8995fcd44b416d2a1604ad9180e9f133c76ed26134df3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2018.08.1597$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Bouras, Georgios</creatorcontrib><creatorcontrib>Abizaid, Alexandre</creatorcontrib><creatorcontrib>Lutz, Matthias</creatorcontrib><creatorcontrib>Carrie, Didier</creatorcontrib><creatorcontrib>Weber-Albers, Joachim</creatorcontrib><creatorcontrib>Dudek, Darius</creatorcontrib><creatorcontrib>Gambone, Louise</creatorcontrib><creatorcontrib>Anderson, Jeffrey</creatorcontrib><creatorcontrib>Lansky, Alexandra</creatorcontrib><title>TCT-432 FANTOM II trial: Safety &amp; Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results</title><title>Journal of the American College of Cardiology</title><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Cardiology</subject><subject>Rapamycin</subject><subject>Success</subject><subject>Surgical implants</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kUuOEzEQhi0EEiFwAjYlIbHrHj_6icRiaE0zkWYIImFtOX4wbrnbwXYzyo47cAuOxUnoKKxZVZX0_6X660PoNcE5waS6GvJBSJlTTJocNzkp2_oJWpGybDK29E_RCteszAhu6-foRYwDxrhqSLtCv_fdPisYhf760357D5sNpGCFewc7YXQ6wVv4rIPxYRST1LBLszqBN5AeNPRiSn6EnQ3e2XGO2Y2bk52-wQfrg44-HMTBaeh88JMIJ9hJYYx3Cv78_AW0yO79lB6g9875x2w-QufsZKVwsJ2T9KOO0NtpGb_oOLsUX6JnRrioX_2ra_S1v9l3t9nd9uOmu77LJKWkzmgpW4WxofhQsroSRNSmadvSSFUUh4JUigpS4UKoljRYt4YwJutKK1oRVijD1ujNZe8x-O-zjokPfg7LIZFTQhjFBV6Ua8QuKhl8jEEbfgx2XGJygvkZCh_4GQo_Q-G44Wcoi-v9xaWXAD-sDjxKq5fPKhu0TFx5-1__X0WTlb8</recordid><startdate>20180925</startdate><enddate>20180925</enddate><creator>Bouras, Georgios</creator><creator>Abizaid, Alexandre</creator><creator>Lutz, Matthias</creator><creator>Carrie, Didier</creator><creator>Weber-Albers, Joachim</creator><creator>Dudek, Darius</creator><creator>Gambone, Louise</creator><creator>Anderson, Jeffrey</creator><creator>Lansky, Alexandra</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20180925</creationdate><title>TCT-432 FANTOM II trial: Safety &amp; Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results</title><author>Bouras, Georgios ; Abizaid, Alexandre ; Lutz, Matthias ; Carrie, Didier ; Weber-Albers, Joachim ; Dudek, Darius ; Gambone, Louise ; Anderson, Jeffrey ; Lansky, Alexandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2217-25c9d00f20b5376a1a7f8995fcd44b416d2a1604ad9180e9f133c76ed26134df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Cardiology</topic><topic>Rapamycin</topic><topic>Success</topic><topic>Surgical implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouras, Georgios</creatorcontrib><creatorcontrib>Abizaid, Alexandre</creatorcontrib><creatorcontrib>Lutz, Matthias</creatorcontrib><creatorcontrib>Carrie, Didier</creatorcontrib><creatorcontrib>Weber-Albers, Joachim</creatorcontrib><creatorcontrib>Dudek, Darius</creatorcontrib><creatorcontrib>Gambone, Louise</creatorcontrib><creatorcontrib>Anderson, Jeffrey</creatorcontrib><creatorcontrib>Lansky, Alexandra</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouras, Georgios</au><au>Abizaid, Alexandre</au><au>Lutz, Matthias</au><au>Carrie, Didier</au><au>Weber-Albers, Joachim</au><au>Dudek, Darius</au><au>Gambone, Louise</au><au>Anderson, Jeffrey</au><au>Lansky, Alexandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCT-432 FANTOM II trial: Safety &amp; Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-09-25</date><risdate>2018</risdate><volume>72</volume><issue>13</issue><spage>B174</spage><epage>B174</epage><pages>B174-B174</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2018.08.1597</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B174-B174
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2113204061
source ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Biocompatibility
Biomedical materials
Cardiology
Rapamycin
Success
Surgical implants
title TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A13%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCT-432%20FANTOM%20II%20trial:%20Safety%20&%20Performance%20Study%20of%20the%20Fantom%20Sirolimus-Eluting%20Bioresorbable%20Coronary%20Scaffold%20%E2%80%93%2024-Month%20Follow-up%20Clinical%20Outcomes%20Final%20Results&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Bouras,%20Georgios&rft.date=2018-09-25&rft.volume=72&rft.issue=13&rft.spage=B174&rft.epage=B174&rft.pages=B174-B174&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2018.08.1597&rft_dat=%3Cproquest_cross%3E2113204061%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2113204061&rft_id=info:pmid/&rft_els_id=S0735109718376046&rfr_iscdi=true